1st February 2018
Enesi Pharma are attending Biotech & Money, London 5-6 February 2018. David Hipkiss, CEO, will be presenting our latest developments in the Inv€$table Biotech Track at 12.30pm on Monday, in the Private Dining area.
6th November 2017
Oxford, UK – 6 November 2017. Enesi Pharma, a clinical-stage company developing unique injectable solid dose drug-device combination products, announces the formation of a new International Scientific Advisory Board (SAB). The SAB includes experts in vaccines and preventative health from leading academic/ research and international health organisations in the US and Europe. Commenting on the… read more
5th October 2017
Oxford, UK – 10 October 2017. Enesi Pharma, a clinical-stage company developing unique injectable solid dose drug-device combination products, announces its launch as a new company at the World Vaccine Congress, which takes place on 10-12 October in Barcelona, Spain. Enesi is focused on the development of innovative vaccines and therapeutics using its proprietary ImplaVax™… read more